Physician profile
Elyssa Noce
NPI 1861913428
$5,389.06
in general payments reported to CMS, 2019-2025
8 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,735 · 2023: $2,399 · 2024: $109 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,195 · Consulting Fee: $1,012 · Food and Beverage: $444 · Education: $3.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,195.20 |
| Consulting Fee | $1,012.00 |
| Food and Beverage | $443.65 |
| Education | $3.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $4,050.39 | 2022-2024 | Tolvaptan |
| Bayer Healthcare Pharmaceuticals INC. | $1,012.00 | 2023 | |
| Aurinia Pharma U.S., INC. | $125.00 | 2023 | |
| Cequr Corporation | $89.30 | 2025 | Cequr Simplicity |
| Biohaven Pharmaceutical Holding Company LTD. | $52.60 | 2022 | |
| Amgen INC. | $29.10 | 2025 | Evenity |
| Novo Nordisk INC | $27.59 | 2025 | Ozempic |
| Travere Therapeutics, INC. | $3.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elyssa Noce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.